Show simple item record

dc.contributor.advisorJamiruddin, Mohd. Raeed
dc.contributor.authorHoque, Md. Ikramul
dc.date.accessioned2021-12-06T06:46:04Z
dc.date.available2021-12-06T06:46:04Z
dc.date.copyright2021
dc.date.issued2021-01
dc.identifier.otherID 16346029
dc.identifier.urihttp://hdl.handle.net/10361/15697
dc.descriptionThis thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.en_US
dc.descriptionCataloged from PDF version of thesis report.
dc.descriptionIncludes bibliographical references (pages 35-39).
dc.description.abstractA new public health disaster arises with the spreading of novel coronavirus in early December 2019, originated in Wuhan City, Hubei Province, China. The novel coronavirus which is identified as Coronavirus Disease 2019 (COVID-19) was accountable for causing pneumonia like disease to patients after that novel coronavirus is identified as Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). It is assumed that bat is the primary source of coronavirus because its homology matches 80% to SARS-CoV which is responsible for acute respiratory distress syndrome (ADRS). Because of this virus World Health Organization (WHO) officially announced a pandemic throughout the world on March 11, 2020. SARS-CoV-2 is highly transmittable from human to human, more than 99,804,787 confirmed cases and 2,139,791 thousand confirmed deaths and 71,797,201 recovered cases globally to date (25/01/2021) according to WHO. SARS-CoV-2 virus firstly affects respiratory system and other organ systems too as time passes. Symptoms starting from fever, dry cough, tiredness and to serious symptoms includes difficulty breathing or shortness of breath, chest pain, loss of speech or movement and multiple organ dysfunction which leads to death. As a result, an immediate treatment option in needed for this current situation. Although, several potent antiviral drugs, vaccines are under urgent investigation but no candidate found so far for SARS-CoV-2 virus. In this literature review we summarized all the latest research progress of the causative agent, pathogenesis, epidemiology, immune response, clinical characteristics, diagnosis, treatment, management of diseases, control, prevention strategies of COVID-19.en_US
dc.description.statementofresponsibilityMd Ikramul Hoque
dc.format.extent39 pages
dc.language.isoenen_US
dc.publisherBrac Universityen_US
dc.rightsBrac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission.
dc.subjectCovid-19en_US
dc.subjectNovel coronavirusen_US
dc.subjectSARS-CoV-2en_US
dc.subjectWHOen_US
dc.subjectVaccinesen_US
dc.subjectpathogenesisen_US
dc.subject.lcshCOVID-19 (Disease)--Prevention
dc.titleLiterature review of prospective drugs for COVID-19en_US
dc.typeThesisen_US
dc.contributor.departmentDepartment of Pharmacy, Brac University
dc.description.degreeB. Pharmacy


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record